Commission Decision

of 14 April 2009

concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

(notified under document number C(2009) 2566)

(Text with EEA relevance)

(2009/324/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market1, and in particular the second subparagraph of Article 16(2) thereof,

Whereas:

(1)
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market2 establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
(2)

For a number of substance/product type combinations included in that list, the original participants discontinued their participation in the review programme.

(3)

Consequently, and pursuant to Articles 11(2), 12(1) and 13(5) of Regulation (EC) No 1451/2007, the Commission informed the Member States thereof. That information was also made public by electronic means on 14 June 2006.

(4)

Within the period of three months from that publication, other persons indicated an interest in taking over the role of participant for some substance/product type combinations.

(5)
Commission Decision 2007/794/EC3 fixed the new deadline for the submission of a complete dossier to 30 April 2008 for these substance/product type combinations.
(6)

No complete dossiers were however received within this time period for certain of these substance/product type combinations.

(7)

Pursuant to Articles 12(4) and 12(5) of Regulation (EC) No 1451/2007, the substances should therefore not be included for the product-types concerned in Annexes I, IA or IB to Directive 98/8/EC.

(8)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS DECISION: